Racial disparities in guideline-concordant cancer care and mortality in the United States.

ABSTRACT:

Purpose

We identified the frequency of racial disparities in guideline-concordant cancer care for select common disease sites in the United States and the impact of guideline concordance on mortality disparities.

Methods and materials

Using Surveillance, Epidemiology, and End Results Medicare data, we evaluated patients age >65 years of black or non-Hispanic white race who were diagnosed with stage III breast (n = 3607), stage I (n = 14,605) or III (n = 15,609) non-small cell lung, or stage III prostate (n = 3548) cancer between 2006 and 2011. Chemotherapy, surgery, and radiation therapy (RT) treatments were identified using claims data. Pearson χ² was used to test the associations between race and guideline concordance on the basis of National Comprehensive Cance

SUBMITTER: Fang P 

PROVIDER: S-EPMC6128037 | biostudies-literature | 2018 Jul-Sep

REPOSITORIES: biostudies-literature